Literature DB >> 31371453

Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.

Vasvi Tripathi1, Kiran Sankar Chatterjee1, Ranabir Das2.   

Abstract

Many viral factors manipulate the host post-translational modification (PTM) machinery for efficient viral replication. In particular, phosphorylation and SUMOylation can distinctly regulate the activity of the human cytomegalovirus (HCMV) transactivator immediate early 2 (IE2). However, the molecular mechanism of this process is unknown. Using various structural, biochemical, and cell-based approaches, here we uncovered that IE2 exploits a cross-talk between phosphorylation and SUMOylation. A scan for small ubiquitin-like modifier (SUMO)-interacting motifs (SIMs) revealed two SIMs in IE2, and a real-time SUMOylation assay indicated that the N-terminal SIM (IE2-SIM1) enhances IE2 SUMOylation up to 4-fold. Kinetic analysis and structural studies disclosed that IE2 is a SUMO cis-E3 ligase. We also found that two putative casein kinase 2 (CK2) sites adjacent to IE2-SIM1 are phosphorylated in vitro and in cells. The phosphorylation drastically increased IE2-SUMO affinity, IE2 SUMOylation, and cis-E3 activity of IE2. Additional salt bridges between the phosphoserines and SUMO accounted for the increased IE2-SUMO affinity. Phosphorylation also enhanced the SUMO-dependent transactivation activity and auto-repression activity of IE2. Together, our findings highlight a novel mechanism whereby SUMOylation and phosphorylation of the viral cis-E3 ligase and transactivator protein IE2 work in tandem to enable transcriptional regulation of viral gene.
© 2019 Tripathi et al.

Entities:  

Keywords:  SUMO-interacting motif (SIM); enzyme kinetics; host–pathogen interaction; nuclear magnetic resonance (NMR); phosphorylation; post-translational modification (PTM); sumoylation; transcription co-activator; viral protein; viral transcription

Mesh:

Substances:

Year:  2019        PMID: 31371453      PMCID: PMC6779447          DOI: 10.1074/jbc.RA119.009601

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes.

Authors:  A Marchini; H Liu; H Zhu
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Structural analysis of the major immediate early gene of human cytomegalovirus.

Authors:  R M Stenberg; D R Thomsen; M F Stinski
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

4.  Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.

Authors:  J H Ahn; Y Xu; W J Jang; M J Matunis; G S Hayward
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 5.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Authors:  Jaclyn R Gareau; Christopher D Lima
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

6.  Identification of a substrate recognition site on Ubc9.

Authors:  Donghai Lin; Michael H Tatham; Bin Yu; Suhkmann Kim; Ronald T Hay; Yuan Chen
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

7.  Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2.

Authors:  N Y Harel; J C Alwine
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box.

Authors:  R Jupp; S Hoffmann; A Depto; R M Stenberg; P Ghazal; J A Nelson
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Human cytomegalovirus UL84 oligomerization and heterodimerization domains act as transdominant inhibitors of oriLyt-dependent DNA replication: evidence that IE2-UL84 and UL84-UL84 interactions are required for lytic DNA replication.

Authors:  Kelly S Colletti; Yiyang Xu; Sylvia A Cei; Margaret Tarrant; Gregory S Pari
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 10.  Interplay between viruses and host sumoylation pathways.

Authors:  Roger D Everett; Chris Boutell; Benjamin G Hale
Journal:  Nat Rev Microbiol       Date:  2013-04-29       Impact factor: 60.633

View more
  4 in total

1.  Insights into the Microscopic Structure of RNF4-SIM-SUMO Complexes from MD Simulations.

Authors:  Alex Kötter; Henning D Mootz; Andreas Heuer
Journal:  Biophys J       Date:  2020-09-11       Impact factor: 4.033

2.  Non-covalent Interaction With SUMO Enhances the Activity of Human Cytomegalovirus Protein IE1.

Authors:  Vasvi Tripathi; Kiran Sankar Chatterjee; Ranabir Das
Journal:  Front Cell Dev Biol       Date:  2021-05-13

3.  Site-Specific Protein Ubiquitylation Using an Engineered, Chimeric E1 Activating Enzyme and E2 SUMO Conjugating Enzyme Ubc9.

Authors:  Gaku Akimoto; Arianna P Fernandes; Jeffrey W Bode
Journal:  ACS Cent Sci       Date:  2022-02-09       Impact factor: 14.553

4.  Stability of Begomoviral pathogenicity determinant βC1 is modulated by mutually antagonistic SUMOylation and SIM interactions.

Authors:  Ashwin Nair; Kiran Sankar Chatterjee; Vikram Jha; Ranabir Das; P V Shivaprasad
Journal:  BMC Biol       Date:  2020-08-31       Impact factor: 7.431

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.